By Georgi Kantchev The Wall Street Journal Mike Bird Mon., Dec. 3, 2018 U.S. stocks were poised to open sharply higher on Monday and global markets rallied after a cease-fire in the trade spat between the U.S. and China boosted investor sentiment following a rocky stretch for risk assets. Futures pointed to opening gains of 1.5% for the S&P 500 and 1.8% for the Dow Jones Industrial Average. In Europe, the Stoxx Europe 600 rose 1.3%, led by gains in autos and resources stocks. Asian markets finished sharply higher and the Chinese yuan gained against the dollar. Oil prices also climbed sharply, with Brent crude, the global price benchmark, jumping 3.7% to $61.62 (U.S.) a barrel after Russia and Saudi Arabia agreed to extend efforts by the Organization of the Petroleum Exporting Countries to curb production and Canada’s oil-rich province of Alberta also ordered a limit on output. On the trade front, President Trump and Chinese President Xi Jinping … [Read more...] about Global markets rally after Trump-Xi cease-fire eases trade worries
Citigroup global markets limited
Decade After Crisis, a $600 Trillion Market Remains Murky to Regulators
Sections SEARCH Skip to content Skip to site index Business Day Subscribe Log In Subscribe Log In Advertisement Supported by ByEmily Flitter July 22, 2018 In the maze of subsidiaries that make up Goldman Sachs Group, two in London have nearly identical names: Goldman Sachs International and Goldman Sachs International Bank. Both trade financial instruments known as derivatives with hedge funds, insurers, governments and other clients. United States regulators, however, get detailed information only about the derivatives traded by Goldman Sachs International. Thanks to a loophole in laws enacted in response to the financial crisis, trades by Goldman Sachs International Bank don’t have to be reported. A decade after a financial crisis fueled in part by a tangled web of derivatives, regulators still have an incomplete picture of who holds what in this $600 trillion market. “It’s a global market, so you really have … [Read more...] about Decade After Crisis, a $600 Trillion Market Remains Murky to Regulators
Shire plc : Shire announces revised proposal and extension of PUSU deadline to 8 May 2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTIONTHIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADETHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATIONShire plc ("Shire" or the "Company")24 April 2018Shire announces revised proposal and extension of PUSU deadline to 8 May 2018The Board of Shire (the "Board") announced earlier today that it had received a further revised proposal from Takeda Pharmaceutical Company Limited ("Takeda") regarding a possible offer for the Company.The revised proposal comprises 0.839 new Takeda shares and US$30.33 in cash for each Shire ordinary share (the "Revised Proposal").Based on Takeda's share price of ¥4,923 and the … [Read more...] about Shire plc : Shire announces revised proposal and extension of PUSU deadline to 8 May 2018
Shire plc : Statement re revised proposal
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTIONTHIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE.THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATIONShire plc ("Shire" or the "Company")24 April 2018Statement re revised proposalThe Board announces that it has received a revised proposal from Takeda regarding a possible offer for the Company on 24 April 2018.The Board is considering its position.There can be no certainty that any firm offer for the Company will be made nor as to the terms on which any firm offer might be made.This announcement is made without the consent of … [Read more...] about Shire plc : Statement re revised proposal
Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTIONTHIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE.THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATIONShire plc ("Shire" or the "Company")20 April 2018Statement re Proposal from Takeda Pharmaceutical Company Limited ("Takeda")Shire notes the announcement made by Takeda and confirms it has received a fourth proposal on 20 April 2018 regarding a possible offer for the Company (the "Fourth Proposal").The Fourth Proposal comprises £26 per share in new Takeda shares, to be listed in Japan and in the US through an ADR listing, and £21 per … [Read more...] about Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited